Open AccessAbstract 212: High-resolution barcoding in patient-derived xenografts of triple-negative breast cancer reveals reversible chemoresistance conferred by non-mutational mechanisms
Author(s) -
Gloria V. Echeverria,
Sahil Seth,
Zhongqi Ge,
Alessandro Carugo,
Christopher A. Bristow,
Prabjhot Mundi,
Sabrina Jeter-Jones,
Xiaomei Zhang,
Xinhui Zhou,
Aaron McCoy,
Shirong Cai,
Yizheng Tu,
Yuting Sun,
Joseph R. Marszalek,
Andrea Califano,
W. Fraser Symmans,
Stacy L. Moulder,
Jeffery T. Chang,
Timothy P. Heffernan,
Helen PiwnicaWorms
Publication year - 2018
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2018-212
Subject(s) - cancer research , cancer , chemotherapy , triple negative breast cancer , breast cancer , biology , somatic evolution in cancer , primary tumor , minimal residual disease , oncology , pathology , medicine , metastasis , genetics , bone marrow